Tag(s):

Browse Tags

KFTC guidelines expand patent focus

Friday, 03 February 2012

The KFTC has introduced antitrust guidelines on standard setting
Korea’s Fair Trade Commission (KFTC) has published new guidelines regarding possible anti-competitive use of patents, focusing on standard setting.

US Judge rejects complaint in e-book patent dispute

Wednesday, 01 February 2012

Microsoft accuses Barnes and Noble of patent infringement
A US trade judge has rejected Barnes & Noble’s claim that Microsoft is using its patents to distort competition in a dispute related to the use of Google's Android.

Barnes & Noble asks DoJ to investigate Microsoft patents

Wednesday, 09 November 2011

Barnes & Noble's Nook e-reader
US bookseller Barnes & Noble has asked the US Department of Justice’s antitrust division to investigate whether computer software company Microsoft has used questionable patents to try to harm competition in the market for mobile operating systems.

DG Comp enters Samsung-Apple dispute

Monday, 07 November 2011

Samsung Galaxy and Apple iPhone 4
The European Commission has opened a preliminary investigation of Samsung and Apple’s continuing patent disputes.

California rejects challenge to ‘pay-for-delay’ deal

Wednesday, 02 November 2011

A California court ruled 'pay-for-delay' deal was not illegal
A California state court this week rejected an appeal against a $389 million ‘pay-for-delay’ settlement between drug makers Bayer and Barr.

FTC reveals drop in pay-for-delay deals

Wednesday, 26 October 2011

The FTC remains resolute in its battle against reverse payment settlements
The number of so-called “pay-for-delay” patent settlements between branded and generic drug makers declined last year, but potentially anti-competitive settlements continue to be pervasive in the pharmaceutical industry, the US Federal Trade Commission says.

Korea stings GSK in first reverse payment case

Tuesday, 25 October 2011

GSK was in a patent dispute with Dong-A
UK pharmaceutical company GlaxoSmithKline has been fined by South Korea’s Fair Trade Commission for colluding to shut out competition in the country’s medical market.

An interview with Stephen Kon

Monday, 10 October 2011

Stephen Kon
Stephen Kon is head of the EU & competition department at SJ Berwin LLP in London and will be chairing GCR’s Pharmaceutical and Competition Law conference on 18 October 2011. He talks to GCR about his experience in the pharmaceutical industry, and the rapid development of competition law intervention in the sector.

AstraZeneca pays to settle Tropol XL antitrust case

Tuesday, 27 September 2011

AstraZeneca settles Tropol case
Drug maker AstraZeneca has agreed to pay US$20 million to settle a potential class action lawsuit accusing the company of using sham patent litigation to unfairly monopolise the market for the branded heart disease medication Tropol XL.

Rosch opposes Leibowitz plan to change pay-for-delay rules

Wednesday, 21 September 2011

Rosch not in support of Leibowitz on pay-for-delay
Thomas Rosch, a commissioner at the US Federal Trade Commission, has asked a key US lawmaker to deny an attempt to attach pay-for-delay patent settlement reform to a larger, unrelated debt reduction bill.

Leibowitz backs Obama plan to end pay-for-delay settlements

Tuesday, 20 September 2011

FTC building, Washington, DC
The chairman of the US Federal Trade Commission has pledged support for a component of President Barack Obama’s deficit reduction plan that would make it harder for branded drug companies to settle patent litigation by paying their generic rivals.

DoJ looks into group that purchased Nortel patents

Tuesday, 02 August 2011

The DoJ has questions about a patent bidding consortium
The US Department of Justice’s antitrust division has begun an in-depth examination of why a group of the world’s largest technology companies banded together and paid a far-higher-than-expected price to buy patents targeted by online search operator Google.

Pay-for-delay deals continue to fall in Europe

Thursday, 07 July 2011

The number of patent settlements in Europe’s pharmaceutical industry that could potentially violate antitrust law continues to decline, according to European Commission statistics released yesterday.

Judge dismisses lottery ticket patent suit

Premium Article - Thursday, 20 January 2011

A US federal judge has dismissed an antitrust lawsuit claiming that a lottery ticket company was using an invalid patent to unfairly raise prices to a competitor and attempt to monopolise the market.

US states file brief with Supreme Court in Cipro case

Premium Article - Wednesday, 12 January 2011

A group of 32 state attorneys general have told the US Supreme Court that they need clarification on the legality of pay-for-delay pharmaceutical settlements - which only the high court can provide.

Back to top

Law Business Research Ltd

87 Lancaster Road, London
W11 1QQ, UK
International Bar Association logo American Bar Association strategic partner logo

Copyright © 2012 Law Business Research Ltd. All rights reserved. | http://www.lbresearch.com

87 Lancaster Road, London, W11 1QQ, UK | Tel: +44 207 908 1188 / Fax: +44 207 229 6910

http://www.globalcompetitionreview.com | editorial@globalcompetitionreview.com